you are here:

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals

BSE Live

Jun 23, 15:49
1072.85 -16.45 (-1.51%)
Volume
AVERAGE VOLUME
5-Day
45,175
10-Day
70,668
30-Day
66,687
20,114
  • Prev. Close

    1089.30

  • Open Price

    1095.75

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1072.85 (6)

NSE Live

Jun 23, 15:48
1072.45 -15.15 (-1.39%)
Volume
AVERAGE VOLUME
5-Day
889,856
10-Day
915,690
30-Day
1,067,170
360,142
  • Prev. Close

    1087.60

  • Open Price

    1097.00

  • Bid Price (Qty.)

    1072.45 (24)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Yearly Results of Natco Pharma (in Rs. Cr.) Mar '21 Mar '20 Mar '19 Mar '18 Mar '17  
Net Sales/Income from operations 1,653.50 1,790.20 1,986.30 2,091.30 2,002.80  
Other Operating Income -- -- -- -- --  
Total Income From Operations 1,653.50 1,790.20 1,986.30 2,091.30 2,002.80  
EXPENDITURE  
Consumption of Raw Materials 372.90 329.00 333.10 390.50 520.80  
Purchase of Traded Goods 174.00 123.90 31.50 22.70 68.70  
Increase/Decrease in Stocks -46.90 -55.90 -25.50 -24.70 -16.70  
Power & Fuel -- -- -- -- --  
Employees Cost 380.00 356.10 340.20 312.20 232.10  
Depreciation 115.20 98.10 80.10 65.50 53.60  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 355.90 459.10 490.50 462.20 505.90  
P/L Before Other Inc. , Int., Excpt. Items & Tax 302.40 479.90 736.40 862.90 638.40  
Other Income 101.10 123.80 129.80 39.40 13.20  
P/L Before Int., Excpt. Items & Tax 403.50 603.70 866.20 902.30 651.60  
Interest 11.30 20.60 18.80 14.70 17.50  
P/L Before Exceptional Items & Tax 392.20 583.10 847.40 887.60 634.10  
Exceptional Items -- -- -- -- --  
P/L Before Tax 392.20 583.10 847.40 887.60 634.10  
Tax 82.70 108.60 180.30 189.40 139.30  
P/L After Tax from Ordinary Activities 309.50 474.50 667.10 698.20 494.80  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 309.50 474.50 667.10 698.20 494.80  
Equity Share Capital 36.50 36.40 36.50 36.90 34.90  
Reserves Excluding Revaluation Reserves 4,054.60 3,833.10 3,526.70 3,088.50 1,664.80  
Equity Dividend Rate (%) 262.50 337.50 312.50 412.50 337.50  
EPS Before Extra Ordinary  
Basic EPS 16.99 26.08 36.22 39.38 28.27  
Diluted EPS 16.96 26.01 36.10 39.24 28.24  
EPS After Extra Ordinary  
Basic EPS. 16.99 26.08 36.22 39.38 28.27  
Diluted EPS. 16.96 26.01 36.10 39.24 28.24  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited